'The Effect of Adding LFCN Block to PENG

Pain, Postoperative Clinical Trial

Official title:

The Effect of Adding Lateral Femoral Cutaneous Nerve Block to PENG Block on Postoperative Opioid Consumption in Hip Surgery

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06226675
• Other study ID #: 2020/15-14
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 1, 2023
• Est. completion date: April 1, 2024

Study information

• Verified date: January 2024
• Source: Zonguldak Bulent Ecevit University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The incidence of femoral neck fracture in Europe is 330/10000 per year. It is increasing every year due to the aging of the population. In patients 55 years and older, hip fracture-related mortality is estimated to be between 4% and 16% at one month and between 11% and 43% at one year after surgery. The reduced risk of postoperative complications associated with the use of regional anesthesia, shorter mobilization times, and reduced morphine consumption in hip fractures have been reported, and have been incorporated into postoperative pain control as part of multimodal strategies. PENG has been described for postoperative pain control for surgery on the hip joint or for the treatment of post-traumatic pain associated with proximal femur/femoral head fractures. Lateral femoral cutaneous nerve block is used in combination with other peripheral block methods to provide analgesia in the lateral thigh. The investigators aimed to evaluate the effect of adding lateral femoral cutaneous nerve block to PENG block on pain scores and opioid consumption in femoral fracture procedures under spinal anesthesia.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 60
• Est. completion date: April 1, 2024
• Est. primary completion date: January 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• 18-75 years old,
• ASA I-II-III risk group
• patients undergoing hip fracture surgery under spinal anesthesia
• Patients whose informed consent was read and consent was obtained from them and their representatives.

Exclusion Criteria:

• Those who do not want to participate in the study,
• ASA IV-V patients
• Those with coagulation disorders
• Allergic to local anesthetics

Related Conditions & MeSH terms

• Acute Pain
• Nerve Block
• Opioid Consumption
• Pain, Acute
• Pain, Postoperative

Intervention

Procedure:
• PENG Block
To apply local anesthetic under psoas tendon
• LFCN block
to apply local anesthetic around lateral femoral cutaneous nerve

Locations

Country	Name	City	State
Turkey	Zonguldak Bülent Ecevit University	Zonguldak	Kozlu

Sponsors (1)

Lead Sponsor	Collaborator
Zonguldak Bulent Ecevit University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative opioid consumption	total morphine requirement	up to 24 hour after surgery
Secondary	pain scores	evaluating pain scores by Numeric Rating Score	up to 24 hour after surgery
Secondary	first analgesic time	the need of first analgesic after surgery	up to 24 hour after surgery
Secondary	postoperative complications	nausea-vomitting, motor block, hypertension, hypotension etc.	up to 24 hour after surgery
Secondary	mobilization time	when the patient is first mobilized	up to 24 hour after surgery